The evidence-based guidelines for testing individuals at risk of latent or active TB infection include recommendations on interferon-gamma release and molecular assays.
The organization has been scaling up its use of NGS and bioinformatics and a recent NARMS publication is the first of many that will incorporate sequencing data.
An investigation and follow-up analysis concluded that the Trioplex test promoted by the CDC was equally sensitive to an alternative singleplex Zika assay, despite the microbiologist's claims to the contrary.
